stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  afrances cac  opens  lower at  alinde profit slides on restructuring costs auks ftse  opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  afrances cac  opens  lower at  alinde profit slides on restructuring costs auks ftse  opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  kadmon holdings inc private company information  bloomberg july    am et biotechnology company overview of kadmon holdings inc snapshot people company overview kadmon holdings inc a biopharmaceutical company discovers develops and commercializes small molecules and biologics within autoimmune and fibrotic oncology and genetic diseases the company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis c virus infection and distributes products in various therapeutic areas including those indicated for the management of rare diseases its lead product candidates include kd a rhoassociated coiledcoil kinase inhibitor which is in phase ii clinical studies for the treatment of autoimmune fibrotic and neurodegenerative diseases tesevatinib an oral tyrosine kinase inhibitor that is in phase i kadmon holdings inc a biopharmaceutical company discovers develops and commercializes small molecules and biologics within autoimmune and fibrotic oncology and genetic diseases the company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis c virus infection and distributes products in various therapeutic areas including those indicated for the management of rare diseases its lead product candidates include kd a rhoassociated coiledcoil kinase inhibitor which is in phase ii clinical studies for the treatment of autoimmune fibrotic and neurodegenerative diseases tesevatinib an oral tyrosine kinase inhibitor that is in phase ii clinical studies for use in the treatment of nonsmall cell lung cancer and glioblastoma as well as for treating autosomal dominant polycystic kidney disease and kd that is used for the treatment of wilson’s disease a genetic liver disease kadmon holdings inc has a strategic collaborations and license agreements with symphony evolution inc nano terra inc dyax corp chiromics llc vivus inc meiragtx limited abbvie inc zydus pharmaceuticals usa inc jinghua pharmaceutical group co ltd and camber pharmaceuticals inc the company is headquartered in new york new york detailed description  east th streetnew york ny united states employees phone  fax  wwwkadmoncom key executives for kadmon holdings inc dr harlan w waksal md chief executive officer president and director age  total annual compensation m mr konstantin poukalov chief financial officer and executive vice president age  total annual compensation k mr steven n gordon jd esq chief administrative compliance  legal officer executive vice president and general counsel age  total annual compensation k compensation as of fiscal year  kadmon holdings inc key developments kadmon holdings inc announces supplemental interim phase  data of kd in chronic graftversushost disease jul   kadmon holdings inc announced supplemental clinical data from the first cohort kd  mg qd of an ongoing phase  clinical trial kd of the company’s lead rhoassociated coiledcoil kinase  rock inhibitor kd for chronic graftversushost disease cgvhd the company first announced clinical data from the study on july   the data points which were pending at the time of the prior data release are as follows an additional responder sustained a response through  weeks of kd treatment of responders remaining on kd through  weeks  of   sustained responses up from  of  patients  previously reported an additional patient achieved stable disease at week  this finding brings the number of patients with stable disease at week  to three patients up from two patients previously reported and increases the overall clinical benefit response and stable disease to   of patients up from   of patients the full data from the first cohort have been updated to reflect these points as follows kd is an ongoing phase  clinical trial evaluating the safety tolerability and activity of kd in adults with steroiddependent or steroidrefractory cgvhd and active disease the dosefinding study includes  patients divided into three cohorts at different dose levels kd  mg qd  mg bid and  mg qd enrolled sequentially following a safety assessment of each cohort in a preliminary analysis of data from the first cohort kd  mg qd n kd demonstrated clinically meaningful responses in cgvhd patients with an overall response rate orr of   which includes complete and partial responders of responders remaining on kd through week   of   sustained responses in addition to the  responders three patients have stable disease and remain on kd through week  overall clinical benefit response and stable disease occurred in   of patients kadmon holdings inc  special call jul   research and development day kadmon holdings inc announces interim phase  data of kd in chronic graftversushost disease jul   kadmon holdings inc announced positive interim results from its ongoing phase  clinical trial evaluating kd the company’s rhoassociated coiledcoil kinase  “rock” inhibitor in patients with previously treated chronic graftversushost disease “cgvhd” a serious complication following allogeneic bone marrow or stem cell transplantation in a preliminary analysis kd demonstrated a favorable safety and tolerability profile in all patients and an overall response rate “orr” of  kd is an ongoing phase  clinical trial evaluating the safety tolerability and activity of kd in adults with steroiddependent or steroidrefractory cgvhd and active disease the dosefinding study includes  patients divided into three cohorts at different dose levels kd  mg qd  mg bid and  mg qd enrolled sequentially following a safety assessment of each cohort in a preliminary analysis of data from the first cohort kd  mg qd n kd demonstrated clinically meaningful responses in cgvhd patients with an orr of   which includes complete and partial responders of responders remaining on kd through week   of   sustained responses in addition to the  responders two patients have stable disease and remain on kd through week  overall clinical benefit response and stable disease occurred in   of patients   of responders saw an improvement in symptoms as measured by the lee cgvhd symptom scale score to date no drugrelated serious adverse events saes have been recorded and no drugrelated elevations in liver function tests have been observed importantly   of responders had reduction of steroid doses and   of patients had reduction of tacrolimus doses similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement march    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact kadmon holdings inc please visit wwwkadmoncom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  afrances cac  opens  lower at  alinde profit slides on restructuring costs auks ftse  opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  kdmn profile  kadmon holdings inc stock  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets open in  hrs  minssp futures dow futures kadmon holdings inc kdmnnyse  nyse delayed price currency in usdadd to watchlist at close pm edtpeople also watchsyrsmrussndxboldptgxsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystskadmon holdings inc east th streetnew york ny united stateshttpwwwkadmoncomsector industry full time employees key executivesnametitlepayexercisedagedr harlan w waksal mdchief exec officer pres and directormnamr konstantin poukalovchief financial officer and exec vpknamr steven n gordon jd esqchief admin compliance  legal officer exec vp and gen counselknadr john l ryan md phdchief medical officer and exec vpnanadr lawrence k cohen phdexec vp of bus develnanaamounts are as of december   and compensation values are for the last fiscal year ending on that date pay is salary bonuses etc exercised is the value of options exercised during the fiscal year currency in usddescriptionkadmon holdings inc a biopharmaceutical company discovers develops and commercializes small molecules and biologics within autoimmune and fibrotic oncology and genetic diseases the company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis c virus infection and distributes products in various therapeutic areas including those indicated for the management of rare diseases its lead product candidates include kd a rhoassociated coiledcoil kinase inhibitor which is in phase ii clinical studies for the treatment of autoimmune fibrotic and neurodegenerative diseases tesevatinib an oral tyrosine kinase inhibitor that is in phase ii clinical studies for use in the treatment of nonsmall cell lung cancer and glioblastoma as well as for treating autosomal dominant polycystic kidney disease and kd that is used for the treatment of wilsons disease a genetic liver disease kadmon holdings inc has a strategic collaborations and license agreements with symphony evolution inc nano terra inc dyax corp chiromics llc vivus inc meiragtx limited abbvie inc zydus pharmaceuticals usa inc jinghua pharmaceutical group co ltd and camber pharmaceuticals inc the company is headquartered in new york new yorkcorporate governancekadmon holdings inc’s iss governance qualityscore as of july   is  the pillar scores are audit  board  shareholder rights  compensation corporate governance scores courtesy of institutional shareholder services iss scores indicate decile rank relative to index or region a decile score of  indicates lower governance risk while a  indicates higher governance riskyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated kdmn stock price  kadmon holdings inc stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a prince william and kate middleton are hiring— though not for these weird five royal family jobs a set yourself up to get the most out of retirement a updated european stocks sell off as ubs falls tech worries weigh a rightmove profit rises on ad sales a how do i get a reverse mortgage a bank of ireland profit falls to restart dividend a us tech stocks shape up for another day of selling after amazon disappoints a this city’s subway system will soon run entirely on renewable energy a ‘skinny’ repeal of obamacare fails to pass in latenight senate vote a ubs credit suisse profit up after strategic shift to be replaced home investing quotes stocks united states kdmn overview compare quotes stock screener earnings calendar sectors nyse kdmn us nyse join td ameritrade find a broker kadmon holdings inc watchlist createkdmnalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones kadmon holdings started at neutral with  stock price target at citigroup aug   at  am et by tomi kilgore shares of kadmon founded by sam waksal slump in market debut jul   at  pm et by caitlin huston kadmon holdings trading below  issue price in market debut jul   at  am et by caitlin huston kadmon holdings trading below issue price in market debut jul   at  am et by caitlin huston kadmon shares down  jul   at  am et by caitlin huston sam waksals kadmon holdings prices ipo jul   at  pm et by claudia assis breaking sam waksals kadmon prices ipo at  a share jul   at  pm et by claudia assis kadmon a drug developer launched by sam waksal slumps in trading debut jul   at  pm et on the wall street journal deals of the day analog nabs linear leeco buys vizio jul   at  am et on the wall street journal redemption on offer as disgraced executive sam waksal’s startup launches ipo jul   at  pm et on the wall street journal recent news other news press releases kadmon holdings inc kdmn update on kd in chronic graftversushost disease cgvhd  slideshow kadmon holdings inc kdmn update on kd in chronic graftversushost disease cgvhd  slideshow jul   at  am et on seeking alpha small caps outperform in june  best etfs  stocks small cap stocks have regained their sheen and outperformed the broader us market in june jun   at  am et on zackscom kadmon holdings kdmn shares march higher can it continue kadmon holdings inc kdmn has been on the move lately as the stock has risen by  in the past four weeks and it is currently trading well above its day sma jun   at  am et on zackscom daily insider ratings round up  che iff dltr ahh arex krp daily insider ratings round up  che iff dltr ahh arex krp jun   at  pm et on seeking alpha  biomedical stocks that are expected to surge with the promise of regulatory reform on the horizon investors have been excited about the biomedical space throughout the year if you want to add some to your portfolio check out these  biomedical stocks that are primed to skyrocket here jun   at  pm et on zackscom kadmon holdings kdmn presents at jefferies  global healthcare conference  slideshow kadmon holdings kdmn presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha tracking dan loebs third point portfolio  q  update tracking dan loebs third point portfolio  q  update may   at  pm et on seeking alpha q kadmon holdings inc q kadmon holdings inc may   at  am et on edgar online  edg  q k k kadmon holdings inc mar   at  pm et on edgar online  edg  q k kadmon holdings initiating coverage with buy rating and first price target of  mar   at  am et on seeking alpha jazz pharma isnt dozing stock breaks out on sleep apnea trial mar   at  pm et on investors business daily insiderinsightscom daily round up  jamba medley capital fifth street finance mar   at  am et on seeking alpha premarket analyst action  healthcare mar   at  am et on seeking alpha tracking dan loebs third point portfolio  q  update feb   at  pm et on seeking alpha investors in new issues embrace s new reality jan   at  pm et on seeking alpha hottest manufacturing stocks now – dprx tcon catb zyne dec   at  am et on investorplacecom companies look to fill brain metastasis niche dec   at  pm et on seeking alpha kadmon holdings kdmn investor presentation  slideshow nov   at  am et on seeking alpha tracking dan loebs third point portfolio  q  update nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – xlrn kpti soda prta nov   at  am et on investorplacecom kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease jul   at  am et on businesswire  bzx kadmon announces interim phase  data of kd in chronic graftversushost disease kadmon announces interim phase  data of kd in chronic graftversushost disease jul   at  am et on businesswire  bzx kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day jun   at  am et on businesswire  bzx kadmon to present at the jefferies  global healthcare conference kadmon to present at the jefferies  global healthcare conference jun   at  am et on businesswire  bzx kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and inflammatory conditions kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and inflammatory conditions jun   at  am et on businesswire  bzx robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders may   at  pm et on businesswire  bzx scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn may   at  pm et on pr newswire  prf kadmon provides business update and reports first quarter  financial results kadmon provides business update and reports first quarter  financial results may   at  am et on businesswire  bzx kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual meeting kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual meeting may   at  am et on businesswire  bzx kadmon announces publication of clinical data showing kd improved clinical scores in psoriasis patients apr   at  am et on businesswire  bzx kadmon submits second abbreviated new drug application filing for trientine hydrochloride to fda apr   at  am et on businesswire  bzx kadmon announces amendment to credit agreement and related warrants apr   at  am et on businesswire  bzx kadmon presents preclinical data supporting the therapeutic potential of rock inhibition in pulmonary fibrosis mar   at  am et on businesswire  bzx kadmon announces approximately  million equity financing mar   at  am et on businesswire  bzx kadmon presents encouraging data on tesevatinib in egfrmutated nonsmall cell lung cancer with brain metastases andor leptomeningeal metastases dec   at  am et on businesswire  bzx kadmon submits abbreviated new drug application filing for trientine hydrochloride to fda dec   at  pm et on businesswire  bzx kadmon to present at the th annual piper jaffray healthcare conference nov   at  am et on businesswire  bzx kadmon to present additional data demonstrating tesevatinib safety for the treatment of polycystic kidney disease at asn kidney week  nov   at  am et on businesswire  bzx kadmon to present at the jefferies  london healthcare conference nov   at  am et on businesswire  bzx kadmon provides business update and reports third quarter  financial results nov   at  am et on businesswire  bzx kadmon holdings inc kadmon holdings inc is a biopharmaceutical company which engages in discovering developing and commercializing small molecules and biologics its products include ribasphere ribapak tetrabenazine valganciclovir abacavir entecavir lamivudine and zidovudine the company was founded by steven n gordon in september  and is headquartered in new york ny see full profile analyst ratings sell under hold over buy number of ratings  full ratings citi sees kadmons trials as risky initiates with neutral rating aug   at  am et on benzingacom benzingas top initiations aug   at  am et on benzingacom kadmon offers a diverse clinical pipeline and value optionality hc wainwright says aug   at  am et on benzingacom competitors name chg  market cap pdl biopharma inc  m plandai biotechnology inc  m bioblast pharma ltd  m pieris pharmaceuticals inc  m competitor data provided by partner content trending tickers powered by amzn  spy  sbux  uvxy  baba  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience kdmn stock price  kadmon holdings inc stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a prince william and kate middleton are hiring— though not for these weird five royal family jobs a set yourself up to get the most out of retirement a updated european stocks sell off as ubs falls tech worries weigh a rightmove profit rises on ad sales a how do i get a reverse mortgage a bank of ireland profit falls to restart dividend a us tech stocks shape up for another day of selling after amazon disappoints a this city’s subway system will soon run entirely on renewable energy a ‘skinny’ repeal of obamacare fails to pass in latenight senate vote a ubs credit suisse profit up after strategic shift to be replaced home investing quotes stocks united states kdmn overview compare quotes stock screener earnings calendar sectors nyse kdmn us nyse join td ameritrade find a broker kadmon holdings inc watchlist createkdmnalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones kadmon holdings started at neutral with  stock price target at citigroup aug   at  am et by tomi kilgore shares of kadmon founded by sam waksal slump in market debut jul   at  pm et by caitlin huston kadmon holdings trading below  issue price in market debut jul   at  am et by caitlin huston kadmon holdings trading below issue price in market debut jul   at  am et by caitlin huston kadmon shares down  jul   at  am et by caitlin huston sam waksals kadmon holdings prices ipo jul   at  pm et by claudia assis breaking sam waksals kadmon prices ipo at  a share jul   at  pm et by claudia assis kadmon a drug developer launched by sam waksal slumps in trading debut jul   at  pm et on the wall street journal deals of the day analog nabs linear leeco buys vizio jul   at  am et on the wall street journal redemption on offer as disgraced executive sam waksal’s startup launches ipo jul   at  pm et on the wall street journal recent news other news press releases kadmon holdings inc kdmn update on kd in chronic graftversushost disease cgvhd  slideshow kadmon holdings inc kdmn update on kd in chronic graftversushost disease cgvhd  slideshow jul   at  am et on seeking alpha small caps outperform in june  best etfs  stocks small cap stocks have regained their sheen and outperformed the broader us market in june jun   at  am et on zackscom kadmon holdings kdmn shares march higher can it continue kadmon holdings inc kdmn has been on the move lately as the stock has risen by  in the past four weeks and it is currently trading well above its day sma jun   at  am et on zackscom daily insider ratings round up  che iff dltr ahh arex krp daily insider ratings round up  che iff dltr ahh arex krp jun   at  pm et on seeking alpha  biomedical stocks that are expected to surge with the promise of regulatory reform on the horizon investors have been excited about the biomedical space throughout the year if you want to add some to your portfolio check out these  biomedical stocks that are primed to skyrocket here jun   at  pm et on zackscom kadmon holdings kdmn presents at jefferies  global healthcare conference  slideshow kadmon holdings kdmn presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha tracking dan loebs third point portfolio  q  update tracking dan loebs third point portfolio  q  update may   at  pm et on seeking alpha q kadmon holdings inc q kadmon holdings inc may   at  am et on edgar online  edg  q k k kadmon holdings inc mar   at  pm et on edgar online  edg  q k kadmon holdings initiating coverage with buy rating and first price target of  mar   at  am et on seeking alpha jazz pharma isnt dozing stock breaks out on sleep apnea trial mar   at  pm et on investors business daily insiderinsightscom daily round up  jamba medley capital fifth street finance mar   at  am et on seeking alpha premarket analyst action  healthcare mar   at  am et on seeking alpha tracking dan loebs third point portfolio  q  update feb   at  pm et on seeking alpha investors in new issues embrace s new reality jan   at  pm et on seeking alpha hottest manufacturing stocks now – dprx tcon catb zyne dec   at  am et on investorplacecom companies look to fill brain metastasis niche dec   at  pm et on seeking alpha kadmon holdings kdmn investor presentation  slideshow nov   at  am et on seeking alpha tracking dan loebs third point portfolio  q  update nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – xlrn kpti soda prta nov   at  am et on investorplacecom kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease jul   at  am et on businesswire  bzx kadmon announces interim phase  data of kd in chronic graftversushost disease kadmon announces interim phase  data of kd in chronic graftversushost disease jul   at  am et on businesswire  bzx kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day jun   at  am et on businesswire  bzx kadmon to present at the jefferies  global healthcare conference kadmon to present at the jefferies  global healthcare conference jun   at  am et on businesswire  bzx kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and inflammatory conditions kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and inflammatory conditions jun   at  am et on businesswire  bzx robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders may   at  pm et on businesswire  bzx scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn may   at  pm et on pr newswire  prf kadmon provides business update and reports first quarter  financial results kadmon provides business update and reports first quarter  financial results may   at  am et on businesswire  bzx kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual meeting kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual meeting may   at  am et on businesswire  bzx kadmon announces publication of clinical data showing kd improved clinical scores in psoriasis patients apr   at  am et on businesswire  bzx kadmon submits second abbreviated new drug application filing for trientine hydrochloride to fda apr   at  am et on businesswire  bzx kadmon announces amendment to credit agreement and related warrants apr   at  am et on businesswire  bzx kadmon presents preclinical data supporting the therapeutic potential of rock inhibition in pulmonary fibrosis mar   at  am et on businesswire  bzx kadmon announces approximately  million equity financing mar   at  am et on businesswire  bzx kadmon presents encouraging data on tesevatinib in egfrmutated nonsmall cell lung cancer with brain metastases andor leptomeningeal metastases dec   at  am et on businesswire  bzx kadmon submits abbreviated new drug application filing for trientine hydrochloride to fda dec   at  pm et on businesswire  bzx kadmon to present at the th annual piper jaffray healthcare conference nov   at  am et on businesswire  bzx kadmon to present additional data demonstrating tesevatinib safety for the treatment of polycystic kidney disease at asn kidney week  nov   at  am et on businesswire  bzx kadmon to present at the jefferies  london healthcare conference nov   at  am et on businesswire  bzx kadmon provides business update and reports third quarter  financial results nov   at  am et on businesswire  bzx kadmon holdings inc kadmon holdings inc is a biopharmaceutical company which engages in discovering developing and commercializing small molecules and biologics its products include ribasphere ribapak tetrabenazine valganciclovir abacavir entecavir lamivudine and zidovudine the company was founded by steven n gordon in september  and is headquartered in new york ny see full profile analyst ratings sell under hold over buy number of ratings  full ratings citi sees kadmons trials as risky initiates with neutral rating aug   at  am et on benzingacom benzingas top initiations aug   at  am et on benzingacom kadmon offers a diverse clinical pipeline and value optionality hc wainwright says aug   at  am et on benzingacom competitors name chg  market cap pdl biopharma inc  m plandai biotechnology inc  m bioblast pharma ltd  m pieris pharmaceuticals inc  m competitor data provided by partner content trending tickers powered by amzn  spy  sbux  uvxy  baba  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft kdmn key statistics  kadmon holdings inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close kadmon holdings inc nyse kdmn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus kadmon holdings inc market closed  quotes are delayed by  min jul    pm kdmn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description kadmon holdings inc is a biopharmaceutical company which engages in discovering developing and commercializing small molecules and biologics its products include ribasphere ribapak tetrabenazine valganciclovir abacavir entecavir lamivudine and zidovudine the company was founded by steve kadmon holdings inc is a biopharmaceutical company which engages in discovering developing and commercializing small molecules and biologics its products include ribasphere ribapak tetrabenazine valganciclovir abacavir entecavir lamivudine and zidovudine the company was founded by steven n gordon in september  and is headquartered in new york ny valuation pe current  pe ratio with extraordinary items  price to sales ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on total capital  return on invested capital  capital structure total debt to total capital  total debt to total assets  longterm debt to total capital  officers and executives name age officer since title ms eva heyman   chief commercial officer insider actions – purchase – sale  – number of transactions  date name shares transaction value  goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   goldentree asset management lp    disposition at  per share   third point ventures llc    acquisition at  per share   kadmon i llc      harlan w waksal president ceo director    acquisition at  per share   harlan w waksal president ceo director    acquisition at  per share   konstantin poukalov evp chief financial officer    acquisition at  per share   konstantin poukalov evp chief financial officer    acquisition at  per share   konstantin poukalov evp chief financial officer    acquisition at  per share   konstantin poukalov evp chief financial officer    acquisition at  per share  newslatestcompanyuskdmn marketwatch news on kdmn kadmon holdings started at neutral with  stock price target at citigroup  am aug    tomi kilgore shares of kadmon founded by sam waksal slump in market debut  pm july    caitlin huston kadmon holdings trading below  issue price in market debut  am july    caitlin huston kadmon holdings trading below issue price in market debut  am july    caitlin huston kadmon shares down   am july    caitlin huston sam waksals kadmon holdings prices ipo  pm july    claudia assis sam waksals kadmon prices ipo at  a share  pm july    claudia assis newsnonmarketwatchcompanyuskdmn other news on kdmn kadmon holdings inc kdmn update on kd in chronic graftversushost disease cgvhd  slideshow  am july    seeking alpha small caps outperform in june  best etfs  stocks  am june    zackscom kadmon holdings kdmn shares march higher can it continue  am june    zackscom daily insider ratings round up  che iff dltr ahh arex krp  pm june    seeking alpha  biomedical stocks that are expected to surge  pm june    zackscom kadmon holdings kdmn presents at jefferies  global healthcare conference  slideshow  pm june    seeking alpha tracking dan loebs third point portfolio  q  update  pm may    seeking alpha q kadmon holdings inc  am may    edgar online  edg  q k k kadmon holdings inc  pm march    edgar online  edg  q k kadmon holdings initiating coverage with buy rating and first price target of   am march    seeking alpha jazz pharma isnt dozing stock breaks out on sleep apnea trial  pm march    investors business daily insiderinsightscom daily round up  jamba medley capital fifth street finance  am march    seeking alpha premarket analyst action  healthcare  am march    seeking alpha tracking dan loebs third point portfolio  q  update  pm feb    seeking alpha investors in new issues embrace s new reality  pm jan    seeking alpha hottest manufacturing stocks now – dprx tcon catb zyne  am dec    investorplacecom companies look to fill brain metastasis niche  pm dec    seeking alpha kadmon holdings kdmn investor presentation  slideshow  pm nov    seeking alpha tracking dan loebs third point portfolio  q  update  am nov    seeking alpha biggest movers in manufacturing stocks now – xlrn kpti soda prta  am nov    investorplacecom loading more headlines at a glance kadmon holdings inc  east th street new york new york  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m employees  annual report for kdmn newspressreleasecompanyuskdmn press releases on kdmn kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease  am july    businesswire  bzx kadmon announces interim phase  data of kd in chronic graftversushost disease  am july    businesswire  bzx kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day  am june    businesswire  bzx kadmon to present at the jefferies  global healthcare conference  am june    businesswire  bzx kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and inflammatory conditions  am june    businesswire  bzx robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders  pm may    businesswire  bzx scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn  pm may    pr newswire  prf kadmon provides business update and reports first quarter  financial results  am may    businesswire  bzx kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual meeting  am may    businesswire  bzx kadmon announces publication of clinical data showing kd improved clinical scores in psoriasis patients  am april    businesswire  bzx kadmon submits second abbreviated new drug application filing for trientine hydrochloride to fda  am april    businesswire  bzx kadmon announces amendment to credit agreement and related warrants  am april    businesswire  bzx kadmon presents preclinical data supporting the therapeutic potential of rock inhibition in pulmonary fibrosis  am march    businesswire  bzx kadmon announces approximately  million equity financing  am march    businesswire  bzx kadmon presents encouraging data on tesevatinib in egfrmutated nonsmall cell lung cancer with brain metastases andor leptomeningeal metastases  am dec    businesswire  bzx kadmon submits abbreviated new drug application filing for trientine hydrochloride to fda  pm dec    businesswire  bzx kadmon to present at the th annual piper jaffray healthcare conference  am nov    businesswire  bzx kadmon to present additional data demonstrating tesevatinib safety for the treatment of polycystic kidney disease at asn kidney week   pm nov    businesswire  bzx kadmon to present at the jefferies  london healthcare conference  am nov    businesswire  bzx kadmon provides business update and reports third quarter  financial results  am nov    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  afrances cac  opens  lower at  alinde profit slides on restructuring costs auks ftse  opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  ﻿ kadmon holdings inc thank you thank you for visiting wwwkadmoncom  you will now be redirected to an external website disclaimer the website you have selected is an external one and you will now be leaving wwwkadmoncom  kadmon has no responsibility for any external websites  we neither endorse the information content presentation or accuracy nor make any warranty express or implied regarding any external websites continue to leave kadmoncom continue cancel loading developing innovative medicines for significant unmet medical needs learn more pipeline our pipeline of novel drug candidates targets diseases with significant unmet medical need news kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease discovery with groundbreaking drug discovery platforms kadmon is creating the next generation of medicines investors kadmon maintains ongoing open dialogue with the investor community products we offer medicines for serious and rare diseases meet our innovators and industry leaders learn more learn more about our novel drug candidates see our pipeline find our press releases publications and events read more ﻿ pipeline  kadmon holdings inc thank you thank you for visiting wwwkadmoncom  you will now be redirected to an external website disclaimer the website you have selected is an external one and you will now be leaving wwwkadmoncom  kadmon has no responsibility for any external websites  we neither endorse the information content presentation or accuracy nor make any warranty express or implied regarding any external websites continue to leave kadmoncom continue cancel loading pipeline pioneering a new paradigm for drug development our goal is to develop firstinclass innovative therapies for indications with significant unmet medical needs including autoimmune and fibrotic diseases oncology and genetic diseases autoimmune and fibrotic diseases oncology genetic diseases preclinical phase  phase  phase  kd in psoriasis vulgaris kd is an orally available selective small molecule inhibitor of rock rhoassociated coiledcoil kinase  a molecular target in multiple autoimmune fibrotic and neurodegenerative diseases phase  ongoing randomized doubleblind placebocontrolled clinical study to evaluate the safety tolerability and activity of kd in subjects with moderate to severe psoriasis kd in idiopathic pulmonary fibrosis kd is an orally available selective small molecule inhibitor of rock rhoassociated coiledcoil kinase  a molecular target in multiple autoimmune fibrotic and neurodegenerative diseases phase  ongoing study of kd in idiopathic pulmonary fibrosis kd in chronic graftversushost disease kd is an orally available selective small molecule inhibitor of rock rhoassociated coiledcoil kinase  a molecular target in multiple autoimmune fibrotic and neurodegenerative diseases phase  ongoing study of kd in chronic graftversushost disease tesevatinib in nonsmall cell lung cancer tesevatinib is an oral reversible and potent tyrosine kinase inhibitor tki with demonstrated clinical activity against epidermal growth factor receptor egfr tesevatinib is highly penetrant of the bloodbrain barrier which separates the circulating blood from the brain and accumulates in the leptomeninges membranes that protect the brain and spinal cord and kidneys phase  ongoing study of tesevatinib in subjects with nonsmall cell lung cancer nsclc with activating egfr mutations and brain metastases or leptomeningeal disease tesevatinib in glioblastoma tesevatinib is an oral tyrosine kinase inhibitor tki designed to block key molecular drivers of tumor growth metastases and drug resistance tesevatinib has been observed in preclinical studies to cross the bloodbrain barrier which separates the circulating blood from the brain in preclinical and early clinical studies we have observed tesevatinib’s activity against epidermal growth factor receptor egfr a cell surface receptor and its accumulation in the lungs leptomeninges membranes that protect the brain and spinal cord and kidneys phase  ongoing study of tesevatinib in glioblastoma tesevatinib in autosomal dominant polycystic kidney disease tesevatinib is an oral reversible and potent tyrosine kinase inhibitor tki with demonstrated clinical activity against epidermal growth factor receptor egfr tesevatinib is highly penetrant of the bloodbrain barrier which separates the circulating blood from the brain and accumulates in the leptomeninges membranes that protect the brain and spinal cord and kidneys phase a ongoing safety pharmacokinetics and dosefinding study of tesevatinib in subjects with autosomal dominant polycystic kidney disease tesevatinib in autosomal recessive polycystic kidney disease tesevatinib is an oral reversible and potent tyrosine kinase inhibitor tki with demonstrated clinical activity against epidermal growth factor receptor egfr tesevatinib is highly penetrant of the bloodbrain barrier which separates the circulating blood from the brain and accumulates in the leptomeninges membranes that protect the brain and spinal cord and kidneys phase  planned study of tesevatinib in autosomal recessive polycystic kidney disease kd in wilson’s disease kd is our portfolio of trientine hydrochloride formulations for the treatment of wilson’s disease andas submitted abbreviated new drug applications andas for a bottled generic formulation and a roomtemperature stable product were submitted to the us food and drug administration fda in december  and in march  respectively stability and bioequivalence studies completed stability and bioequivalence studies of kd learn more about kadmon and our groundbreaking work view our profile find our press releases publications and events read more ﻿ products  kadmon holdings inc thank you thank you for visiting wwwkadmoncom  you will now be redirected to an external website disclaimer the website you have selected is an external one and you will now be leaving wwwkadmoncom  kadmon has no responsibility for any external websites  we neither endorse the information content presentation or accuracy nor make any warranty express or implied regarding any external websites continue to leave kadmoncom continue cancel loading products we are committed to improving the lives of patients kadmon offers a portfolio of products for the treatment of serious and rare diseases ribasphere® ribapak® ribavirin usp tablets full prescribing information including boxed warning patient medication guide visit ribapakcom ribasphere® ribavirin usp tablets full prescribing information including boxed warning patient medication guide ribasphere® ribavirin capsules  mg full prescribing information including boxed warning patient medication guide tetrabenazine tetrabenazine tablets full prescribing information including boxed warning valganciclovir valganciclovir tablets usp full prescribing information including boxed warning abacavir abacavir tablets usp full prescribing information including boxed warning entecavir entecavir tablets full prescribing information including boxed warning lamivudine lamivudine tablets full prescribing information including boxed warning lamivudine lamivudine tablets hbv full prescribing information including boxed warning lamivudine and zidovudine lamivudine and zidovudine tablets usp full prescribing information including boxed warning medical information for product inquiries or to report an adverse event or product quality complaint for a kadmon marketed product please call  you are encouraged to report negative side effects of prescription drugs to the fda visit wwwfdagovmedwatch or call fda consumer product safety improvement act cpsia certification in accordance with the cpsia of  kadmon certifies that our product’s childresistant packaging comply with the standards established under the poison prevention packaging act of  as amended to receive a copy of a cpsia certificate for a kadmon product please contact medical information at  or medicalinformationkadmoncom learn more about kadmon and our groundbreaking work view our profile we are interested in hearing from you contact us kdmnnew york stock quote  kadmon holdings inc  bloomberg markets error could not add to watchlist x  watchlist kadmon holdings inc kdmnus new york usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  dan loeb owns  of firm founded by sam waksal kdmn  investopedia there are currently no news stories for this ticker please check back later  kadmon announces supplemental interim phase  data of kd in chronic graftversushost disease  kadmon announces interim phase  data of kd in chronic graftversushost disease  kadmon to present interim data on kd in chronic graftversushost disease cgvhd at rd day  kadmon to present at the jefferies  global healthcare conference  kadmon announces data demonstrating the potential of the company’s new glut inhibitors for the treatment of autoimmune and  robbins arroyo llp is investigating the officers and directors of kadmon holdings inc kdmn on behalf of shareholders  scottscott attorneys at law llp announces investigation of kadmon holdings inc kdmn  kadmon provides business update and reports first quarter  financial results  kadmon to present clinical and preclinical data highlighting the role of rock signaling in immune system function at aai annual  kadmon announces publication of clinical data showing kd improved clinical scores in psoriasis patients there are currently no press releases for this ticker please check back later profile kadmon holdings inc operates as a biopharmaceutical company the company engages in the discovery development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need kadmon holdings offers its services in the united states address  east th streetnew york ny united states phone  website wwwkadmoncom executives board members harlan w waksal presidentceo konstantin poukalov exec vpcfo steven n gordon exec vpchief administrative  legal ofcr john ryan exec vpchief medical officer lawrence k cohen exec vpresearch  bus dev show more